|
Volumn 26, Issue 1 SUPPL. 2, 1999, Pages 11-20
|
Kinetic concepts in the systemic drug therapy of breast cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARMUSTINE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
FLUOXYMESTERONE;
GRANULOCYTE COLONY STIMULATING FACTOR;
METHOTREXATE;
MONOCLONAL ANTIBODY;
PACLITAXEL;
PREDNISONE;
THIOTEPA;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
VINBLASTINE;
VINCRISTINE;
BONE MARROW TOXICITY;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER CELL;
CANCER CHEMOTHERAPY;
CARDIOMYOPATHY;
CELL GROWTH;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG CYTOTOXICITY;
DRUG INDUCED DISEASE;
FEMALE;
HUMAN;
HUMAN CELL;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CELL DIVISION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
GENE EXPRESSION;
HUMANS;
PACLITAXEL;
RECEPTOR, ERBB-2;
|
EID: 0033063333
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (37)
|
References (36)
|